Why the study?
New third- and fourth-generation devices have changed the incidence and management of endoleaks after endovascular aneurysm repair.
This comprehensive review outlines the most recent concepts regarding the pathophysiology, risk factors, and management of Type 1 endoleaks after endovascular aneurysm repair.
Answers are grounded in this paper and cite their sources.
May inform Type 1 endoleak management after EVAR; extends concepts but leaves open prospective validation.
Over the past 20 years, there has been tremendous progress in endovascular aneurysm repair techniques and devices. The application of new third- and fourth-generation devices (from 2003 onward) has led to changes in the incidence and management of endoleaks. This comprehensive review aims to outline the most recent concepts with respect to pathophysiology/risk factors and management of Type 1 endoleaks.
No takes yet. Share an insight, caveat, or question.
Gaffey et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: